Landscape of Gout in French Polynesia.
Key facts
- Where
- Faa'a, Papeete, and Pirae, French PolynesiaSee the 6 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
Source: NCT07343336, who can take part
Where in French Polynesia
- Medical Office Dr Antoine ScuillerFaa'a, French PolynesiaContact: Antoine ScuillerTaking people
- Medical Office Dr Cedric GueguenPapeete, French PolynesiaContact: Cedric GueguenTaking people
- Medical Office Dr Voradeth NouanesengsyPapeete, French PolynesiaContact: Voradeth NouanesengsyTaking people
- CH de Polynesie Française PapeetePirae, French PolynesiaContact: Baptiste GerardNot yet recruiting
- Medical Office Dr Nanethida NouanesengsyPirae, French PolynesiaContact: Nanethida NouanesengsyTaking people
- Medical Office Dr Raphael HabibPirae, French PolynesiaContact: Raphael HabibTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Lille Catholic University
- Trial code
- NCT07343336
- Record updated
- 15 January 2026
- Original description
The aim of this research is to characterise the genetic and molecular landscape of gout, inflammation and metabolic diseases, as well as the associated molecular, anthropomorphic and pathological characteristics.Read full original descriptionShow less
FENUA-METABOGOUT : Genetic Landscape of Gout, Inflammation and Metabolic Diseases in French Polynesia.
The aim of this research is to characterise the genetic and molecular landscape of gout, inflammation and metabolic diseases, as well as the associated molecular, anthropomorphic and pathological characteristics.
Inclusion: All participants:; Age between 18 and 75 years old inclusive; Signature of informed consent; Fasting for the collection of biological samples; Declared Polynesian ancestry; Affiliated to a social security scheme; General population group :; Not having participated to the 2021 TOPATA study; Visiting a general practitioner (for whatever reason); Gout Group :; Managed at the rheumatology clinic of the Taaone Hospital Centre (CHT) in Papeete by Dr Baptiste Gérard; Tophaceous gout sub-group:; Present with tophaceous gout; Gout crisis subgroup:; Be within 48 hours of the onset of a gout attack; Agree to return 1 week after inclusion for the second blood and urine sample; 2021 follow-up group:; To have been included in the TOPATA study in 2021; Have taken the genetic and biological samples that generated the genetic and serum urate data for the 2021 study; Have hyperuricaemia without signs of gout OR without hyperuricaemia or gout at the time of inclusion in TOPATA.
Exclusion: People suffering from other inflammatory rheumatic diseases; All participants :; Refusal or inability to understand or give consent; Physical inability to follow and respect the protocol; 1st degree relative*,; Person under guardianship or trusteeship; Pregnant or breast-feeding woman; If several relatives from the same household are eligible to participate, only one person may be included in the study. The choice is left to the discretion of the investigator or the first person met. However, both members of a couple (e.g. husband and wife) may participate; General population group :; Unable to return for sampling if required; Gout group :; Person wearing a knee prosthesis.